Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AGEN Agenus > Detailed Quotes

AGEN Agenus

2.165
+0.115+5.61%
Trading Session 10/03 10:35 ET
High
2.180
Open
2.100
Turnover
1.35M
Low
2.045
Pre Close
2.050
Volume
632.56K
Market Cap
613.05M
P/E(TTM)
11.39
52wk High
5.800
Shares
283.16M
P/E(Static)
Loss
52wk Low
1.250
Float Cap
504.29M
Bid/Ask %
16.85%
Historical High
429.000
Shs Float
232.93M
Volume Ratio
0.73
Historical Low
1.140
Dividend TTM
--
Div Yield TTM
--
P/B
180.42
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.27%
Amplitude
6.59%
Avg Price
2.127
Lot Size
1
Float Cap
504.29M
Bid/Ask %
16.85%
Historical High
429.000
Shs Float
232.93M
Volume Ratio
0.73
Historical Low
1.140
Dividend TTM
--
P/B
180.42
Dividend LFY
--
Turnover Ratio
0.27%
Amplitude
6.59%
Avg Price
2.127
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...